Please provide your email address to receive an email when new articles are posted on . The addition of amivantamab-vmjw to chemotherapy extended PFS among a subset of patients with non-small cell ...
Patients with metastatic castration-resistant prostate cancer who do not benefit from chemotherapy need more effective treatment options Phase 2 CheckMate 650 trial found ipilimumab plus nivolumab ...
Intratumoral delivery of an engineered oncolytic virus (DNX-2401) targeting glioblastoma (GBM) cells combined with subsequent immunotherapy was safe and improved survival outcomes in a subset of ...
MIT researchers have developed a new theoretical framework for studying the mechanisms of treatment interactions. Their approach allows scientists to efficiently estimate how combinations of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results